NEW – PRESSURE-CONTROLLED INTERMITTENT CORONARY OCCLUSION IMPROVES THE VASODILATORY MICROVASCULAR CAPACITY AND REDUCES MYOCARDIAL INJURY IN PATIENTS WITH STEMI.
Scarsini R, Terentes-Printzios D, Shanmuganathan M, Kotronias RA, Borlotti A, Marin F, Langrish J, Lucking A, Ribichini F; OxAMI Study, Kharbanda R, Ferreira VM, Channon KM, De Maria GL, Banning AP.
Miracor Medical raises 24M€
Miracor Medical awarded CE Mark for PiCSO Impulse Catheter and Console
Miracor Medical announces PiCSO presentations during PCR e-Course
Miracor Medical granted FDA Breakthrough Device Designation for the PiCSO therapy
Miracor Medical starts PiCSO-AMI-I randomized study in EU
Miracor Medical closes final tranche of Series-D bringing the round to 30€M
Interview of Olivier Delporte, CEO Miracor Medical SA – interview in French
EuroPCR 2018 Presentations – Paris, France, May 25-22
